Want to see PYXS full AI Analyst Report?
Pyxis Oncology (PYXS) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Pembrolizumab, Pyx-201 | Advanced Solid Tumours | phase1AndPhase2 | Recruiting | Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors | Jan 22, 2025 | ― |
| Pyx-201 | Advanced Solid Tumor, Solid Tumor | Phase I | Recruiting | Study of PYX-201 in Solid Tumors | Jan 30, 2023 | ― |
| Pyx-106 | Solid Tumor | Phase I | Active Not Recruiting | Study of PYX-106 in Solid Tumors | Jan 30, 2023 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Pembrolizumab, Pyx-201 | phase1AndPhase2 | Advanced Solid Tumours | Recruiting | Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors | Jan 22, 2025 | ― |
| Pyx-201 | Phase I | Advanced Solid Tumor, Solid Tumor | Recruiting | Study of PYX-201 in Solid Tumors | Jan 30, 2023 | ― |
| Pyx-106 | Phase I | Solid Tumor | Active Not Recruiting | Study of PYX-106 in Solid Tumors | Jan 30, 2023 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Pyxis Oncology, Inc. (PYXS) have in its pipeline
Pyxis Oncology PYXS is currently developing the following drugs: Pembrolizumab, Pyx-201, Pyx-201, Pyx-106. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
